Intrinsiqs

Is Rapport Therapeutics, Inc. Common Stock overvalued?

Rapport Therapeutics, Inc. Common Stock (RAPP) — key valuation metrics and fundamentals.

No verdict
Price
$47.42
Fair value
Current P/E
Normal P/E
Market cap
$2.27B
Dividend yield
0.0%
Return on equity
-29.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares RAPP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.